BOCIC(SH:601696) Xin Lang Cai Jing·2025-10-31 03:13Group 1 - The core viewpoint of the news is that Baipusi has seen a stock price increase of 5.09%, reaching 65.29 CNY per share, with a total market capitalization of 10.959 billion CNY [1] - Baipusi Biotechnology Co., Ltd. specializes in providing key biological reagent products and technical services, with its main business revenue composition being 82.27% from recombinant proteins, 12.88% from antibodies and other reagents, 3.04% from technical services, and 1.80% from other sources [1] Group 2 - According to data, a fund under Bank of China Securities has heavily invested in Baipusi, with the Bank of China Health Industry Mixed Fund (002938) increasing its holdings by 42,300 shares in the third quarter, bringing its total to 141,300 shares, which accounts for 5.29% of the fund's net value [2] - The Bank of China Health Industry Mixed Fund has achieved a year-to-date return of 37.37%, ranking 2279 out of 8154 in its category, and a one-year return of 29.31%, ranking 3054 out of 8046 [2]